NCT04672434 2024-12-09Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSymphogen A/SPhase 1 Completed48 enrolled
NCT03523819 2024-09-19A Study of CS1002 in Subjects with Advanced Solid TumorsCStone PharmaceuticalsPhase 1 Completed91 enrolled
NCT03874897 2024-04-30Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.Peking UniversityPhase 1 Completed134 enrolled